<DOC>
	<DOCNO>NCT00870116</DOCNO>
	<brief_summary>The purpose study evaluate local disease control 2 year patient non-metastatic , non-operated non-small-cell lung cancer treat radiotherapy . Eligible patient recruit register consecutively ( randomization ) . The estimated inclusion period approximately 24 month . The duration research 4 year . The number patient require multicentric prospective study 120 : - 20 patient SBRT-1 arm ( cyberknife ) , - 80 patient SBRT-2 arm ( linear accelerator-based ) - 20 patient conformational radiotherapy arm . This prospective , multicentric , non comparative non randomize study .</brief_summary>
	<brief_title>Stereotactic Body Radio Therapy ( SBRT ) Early-stage Non Small Cell Lung Cancer ( NSCLC )</brief_title>
	<detailed_description>The main objective study health economic evaluation innovate technique radiotherapy . SBRT precise delivery high-powered radiation small target volume , use multiple low-intensity beam . Extremely precise patient position target location essential accurate treatment delivery . Several study show benefit SBRT term local control progression-free survival , particular treatment cerebral metastasis limit number size . The development technique recent . The number treatment session low : 1 4 . But patient expose major risk toxicity several organ : bronchus , lung , large vessel , oesophagus spinal-cord . Pulmonary SBRT impose strict rule use specific equipment . Extra-cranial SBRT realize use either : - Conventional linear-accelerator equip SBRT , - Cyberknife SBRT . 3 group treatment evaluate study : - SBRT cyberknife , - SBRT linear accelerator , - Conformational radiotherapy ( free breathe breath hold ) .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Nonoperated nonsmallcell lung cancer ( NSCLC ) ( inoperable tumor patient refusal surgery ) cytologically histologically proven NSCLC Or primitive pulmonary tumor unproven malignancy macroscopically normal bronchial endoscopy , negative cytology biopsy AND size increase 2 successive scan ( 1012 week interval ) AND hypermetabolic PETCT pattern AND absence proven etiology Tumor &lt; 5cm , distant ( &gt; 1.5 cm ) large vessel , principally bronchus spinalcord No metastasis : M0 No lymph node involvement : N0 Functional respiratory evaluation ( FRE ) compatible thoracic irradiation Maximum expiratory flowvolume &gt; 30 % theoretical value Age &gt; = 18 ECOG PS &lt; = 2 Female patient childbearing potential : effective method contraception Written advice RCP ( conciliation meeting ) present patient file Mandatory affiliation social security system Written , sign informed consent Previously operate tumor Previous thoracic irradiation Previous concurrent primary malignancy site ( except basocellular skin cancer cervical cancer situ complete remission 5 year ) Life expectancy &lt; 6 month Pregnant lactate woman Difficult followup Patient deprive freedom</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>SBRT</keyword>
	<keyword>non-operated</keyword>
	<keyword>non-metastatic</keyword>
	<keyword>non-small-cell lung cancer</keyword>
	<keyword>conformational radiotherapy</keyword>
	<keyword>non-operated non-metastatic non-small-cell lung cancer</keyword>
</DOC>